Amalgamated Bank Meridian Bioscience Inc Transaction History

Amalgamated Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$30.9 - $33.55 $7,632 - $8,286	247 Added 1.19%	21,084 $665,000
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $29,640 - $39,549	1,248 Added 6.37%	20,837 $634,000
Q1 2022 Jun 30, 2022	SELL	$19.97 - $26.94 $20,069 - $27,074	-1,005 Reduced 4.88%	19,589 $509,000
Q4 2021 Feb 15, 2022	SELL	$17.46 - $21.61 $9,690 - $11,993	-555 Reduced 2.62%	20,594 $420,000
Q3 2021 Oct 29, 2021	SELL	$17.35 - $22.5 $5,690 - $7,380	-328 Reduced 1.53%	21,149 $407,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $386,800 - $608,228	21,477 New	21,477 $476,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.